Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Three-year clinical outcomes of resistance genotyping and expert advice: extended follow-up of the Argenta trial.

Antiviral therapy - 1 Jan 2006

De Luca Andrea, Di Giambenedetto Simona, Cingolani Antonella, Bacarelli Alessandra, Ammassari Adriana, Cauda Roberto

Abstract excerpt

OBJECTIVE: To investigate the influence of genotypic resistance-guided HIV-treatment decisions on long-term clinical and virological outcomes in patients failing antiretroviral therapy by a prospective 30-month observation following a 6-month randomized study (Argenta trial). METHODS: Patients (n=174) with virological failure on highly active antiretroviral therapy (HAART) were initially randomized (1:1) to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to HIV Infections

Share to HIV Protease

Share to RNA, Viral

Share to Treatment Failure

Source

Identifiers

PMID: 16759048

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Three-year clinical outcomes of resistance genotyping and expert advice: extended follow-up of the Argenta trial.PMID 16759048Read ↗

Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA).Semantic proximity Read ↗

Antiretroviral drug resistance testing in patients with HIV-1 infection: a meta-analysis study.Semantic proximity Read ↗

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.Semantic proximity Read ↗

Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.Semantic proximity Read ↗

Net benefits of resistance testing directed therapy compared with standard of care in HIV-infected patients with virological failure: A meta-analysis.Semantic proximity Read ↗

Extent of human immunodeficiency virus type 1 drug resistance as a predictor of virological failure after genotype-guided treatment switch.Semantic proximity Read ↗

Virological Outcome After Choice of Antiretroviral Regimen Guided by Proviral HIV-1 DNA Genotyping in a Real-Life Cohort of HIV-Infected Patients.Semantic proximity Read ↗

GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapy.Semantic proximity Read ↗

Persisting long-term benefit of genotype-guided treatment for HIV-infected patients failing HAART. The Viradapt Study: week 48 follow-up.Semantic proximity Read ↗

Impact of genotypic resistance testing on selection of salvage regimen in clinical practice.Semantic proximity Read ↗

Genotypic correlates of resistance to HIV-1 protease inhibitors on longitudinal data: the role of secondary mutations.Semantic proximity Read ↗

Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.